Digital Surveillance & Intelligence Subscription Services

The Food and Drug Administration (FDA) seeks a commercially available, integrated digital intelligence and surveillance platform subscription with service support (Solicitation #75F40125Q00448). This Total Small Business Set-Aside requires a platform providing API access, dashboards, and data feeds to monitor public health risks across digital channels, transitioning the FDA from manual to proactive, automated surveillance. The platform must support five critical use cases: social listening for drug safety, due diligence for bioterrorism, early warning for outbreaks and supply chain disruptions, illegal drug and supplement surveillance, and pharmaceutical advertising monitoring. Critical requirements include the platform's ability to process structured and unstructured data, operate through specialized deep neural architectures mirroring human analytical capabilities, support individual user training and model fine-tuning, maintain ≥95% system uptime, and comply with FDA cybersecurity, privacy, and Section 508 accessibility standards. Proposals, including technical approach and pricing, are due September 19, 2025, at 4:00 PM ET.

Notice ID

b8641b5e695847b98f77fc0d59fa9c93

Solicitation Number

75F40125Q00448

NAICS Code

541519

Classification Code

DA10